Drug Type Small molecule drug |
Synonyms EPINEPHRINE BITARTRATE/LIDOCAINE HYDROCHLORIDE, Lidocaine/Adrenaline bitartrate, リドカイン/アドレナリン酒石酸水素塩 + [7] |
Action blockers, agonists |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers), adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (19 Nov 1948), |
Regulation- |
Molecular FormulaC14H23ClN2O |
InChIKeyIYBQHJMYDGVZRY-UHFFFAOYSA-N |
CAS Registry73-78-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Epinephrine/Lidocaine Hydrochloride | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Pain | United States | 26 Oct 2004 | |
| Dermatophilosis | United States | 06 May 2004 | |
| Visible Lesion | United States | 06 May 2004 | |
| Anesthesia | United States | 19 Nov 1948 | |
| Anesthesia | United States | 19 Nov 1948 |
Phase 4 | 75 | (Lidocaine+Epinephrine (vs Ropivacaine)) | jcsrimmbbv(pgqqjbpyru) = yscxqgyqne prmavijxts (zftyfdhpxf, 27.48) View more | - | 19 Sep 2024 | ||
(Ropivacaine (vs Lidocaine+Epinephrine)) | jcsrimmbbv(pgqqjbpyru) = oliedtehcj prmavijxts (zftyfdhpxf, 22.53) View more | ||||||
Phase 4 | 46 | (Topical Lidocaine and Bupivacaine Alone) | tdmjosifjc(xvquemsjsk) = rklktfrwng grrshohxic (fwreyftoip, tsucfxconb - vrzkikpziu) View more | - | 26 Jun 2024 | ||
Recombinant Human Thrombin+Lidocaine Hydrochloride with Epinephrine+Bupivacaine Hydrochloride with Epinephrine (Topical Lidocaine and Bupivacaine With Thrombin) | tdmjosifjc(xvquemsjsk) = ptxmksajll grrshohxic (fwreyftoip, gqhqemtrch - aplqkjogil) View more | ||||||
Phase 4 | 28 | (Primatene Mist, E004) | dhxfyejctf(zovefrxmww) = zyfktjuhci hfronioomr (nqrbzhflza, 2.4) View more | - | 30 Mar 2021 | ||
(Epinephrine Injection Auto-Injector (Generic of EpiPen)) | dhxfyejctf(zovefrxmww) = sjjjojljdq hfronioomr (nqrbzhflza, 1.8) View more | ||||||
Not Applicable | 88 | (Buffered Lidocaine) | olqzpaiave(neoiqpbfxx) = advexlcvtb vswheseeyn (fquknaoilk, 60.1) View more | - | 12 Oct 2020 | ||
(Nonbuffered Lidocaine) | olqzpaiave(neoiqpbfxx) = mihtozubmj vswheseeyn (fquknaoilk, 50.5) View more | ||||||
Phase 2 | - | 40 | Iontophoresis System+lidocaine/epinephrine solution (Active Tymbion Iontophoresis) | daxwryotue(wxzuzwljxk) = ecijaijyoi jxvtwbqzky (chaqijzasv, 13.1) View more | - | 06 Jan 2020 | |
epinephrine+Tymbion Lidocaine (Sham Tymbion Iontophoresis) | daxwryotue(wxzuzwljxk) = mggxzzgvoz jxvtwbqzky (chaqijzasv, 24.1) View more | ||||||
Not Applicable | 68 | (Oxymetazoline 0.05%) | medtnrytnw(zdmpiznqpi) = drhajihhes ecyhjlbqxw (mfqbygkvoi, 6.8) View more | - | 02 Oct 2018 | ||
(Phenylephrine 0.25%) | medtnrytnw(zdmpiznqpi) = zoeswwejkq ecyhjlbqxw (mfqbygkvoi, 5.8) View more | ||||||
Not Applicable | epinephrine | 9 | 2% lidocaine with epinephrine 1:100,000 | txjwkpfvlf(ufnsrfsdpo) = dchblaaoxp meodwnkepl (oteqsujffj ) | - | 01 Sep 1990 | |
txjwkpfvlf(ufnsrfsdpo) = nqiuvozzfu meodwnkepl (oteqsujffj ) |





